By Lindsay Kalter
Ready to hear about a revolutionary breakthrough? An experimental device filled with millions of stem cells may hold the key to significantly reducing insulin shots for people with type 1 diabetes. This treatment is a potential game-changer that researchers believe could provide a cure for this chronic, life-altering condition. The study, published in the journal Nature Biotechnology, involved 10 people and is showing some promising results.
What’s even more exciting is that there’s hope for these cells to be powerful enough to completely eliminate the need for insulin injections. Dr. David Thompson, the principal investigator, is optimistic that a cure could be within reach as soon as 2024.
Type 1 diabetes can be a particularly challenging and debilitating condition to manage. It’s an autoimmune disease that affects the pancreas’ ability to produce insulin, a hormone that regulates sugar in the blood. Currently, around 1.24 million people in the US live with type 1 diabetes, a number that’s expected to rise in the coming years. There’s no cure for it yet, but this ground-breaking research may change that.
This experimental therapy involves implants filled with lab-grown pancreatic cells known as VC-02. Unlike traditional insulin therapy, these devices are placed just beneath the skin, and they deliver a continuous supply of insulin to the body. This could be a significant improvement that could truly revolutionize the future of treating type 1 diabetes.
For more information about this exciting breakthrough, you can read the full article here.